PillRx only · Shampoo · Topical
Selenium Sulfide
Brands: Cvs Gold · Cvs Health Maximum Strength Dandruff Anti-Seborrheic Dermatitis, Anti-Dandruff · Cvs Health Maximum Strength Dandruff Medicated Anti-Seborrheic Dermatitis, Anti-Dandruff · Careone Medicated Dandruff +25 · Selenium Sulfide
21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US35 NDCs
21 active makers
21 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.058
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
21
Active US suppliers
32%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
8.6K
Rx · 2026 Q1
1.6M
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it21 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| The Procter & Gamble Manufacturing Company | unknown | 7 | SUPPLYING |
| Chattem, Inc. | unknown | 6 | SUPPLYING |
| WALGREEN COMPANY | unknown | 4 | SUPPLYING |
| Meijer Distribution, Inc | unknown | 3 | SUPPLYING |
| TARGET CORPORATION | unknown | 2 | SUPPLYING |
| Laser Pharmaceuticals, LLC | unknown | 2 | SUPPLYING |
| CVS | unknown | 2 | SUPPLYING |
| Davines S.p.A. | unknown | 2 | SUPPLYING |
| GOODSENSE | unknown | 1 | SUPPLYING |
| FAMILY DOLLAR SERVICES INC | unknown | 1 | SUPPLYING |
| Apollo Health and Beauty Care | unknown | 1 | SUPPLYING |
| Westminster Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| Cardinal Health 110, LLC. dba Leader | unknown | 1 | SUPPLYING |
| H E B | unknown | 1 | SUPPLYING |
| RETAIL BUSINESS SERVICES , LLC. | unknown | 1 | SUPPLYING |
+ 7 more labelers
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.